MyHealthChecked PLC Launch of at-home wellness tests (7152O)
14 June 2022 - 4:00PM
UK Regulatory
TIDMMHC
RNS Number : 7152O
MyHealthChecked PLC
14 June 2022
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014
WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL)
ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO
BE IN THE PUBLIC DOMAIN.
MyHealthChecked plc
( " MyHealthChecked " or " the Company " )
Launch of at-home wellness tests
MyHealthChecked launches five new DNA tests into the consumer
home-testing market
MyHealthChecked Plc (AIM: MHC), the consumer home-testing
healthcare company, announces that it has launched five new at-home
cheek swab DNA wellness tests, enabling individuals to make more
informed choices about their health and well-being by providing a
better understanding of their genetic disposition. The tests are
designed to give individuals the power to be more proactive in
unlocking their health potential through the management of diet and
lifestyle.
Each of the tests will be priced at GBP54 and the tests
currently available to purchase are:
-- Intolerances & Sensitivities - to identify genetic
variants associated with intolerances, such as gluten and lactose,
as well as sensitivities, including caffeine, salt and alcohol
-- Weight Management - intended for use by those wishing to
identify their genetic susceptibility to becoming overweight and
their responsiveness to weight loss interventions at a molecular
and metabolic level, including genetic interactions
-- Heart Profile - identifying how individuals respond
differently to diet. This will facilitate optimisation of heart
health parameters by using personalised dietary advice
-- Vitamins & Minerals - this test indicates the
predisposition towards a nutrient deficiency or toxicity, to
highlight nutrients or supplements an individual should increase or
deprioritise
-- Glucose Management - for individuals who aim to follow a
tailored diet to adjust their intake of specific nutrients or foods
to improve their glucose response
The tests will require individuals to take a simple cheek swab
and return their swab in the pre-paid envelope back to
MyHealthChecked's UK lab where data will be handled securely and
accurately. Customers will then be able to access personalised
reports, advice and guidance based on their results through the
MyHealthChecked portal.
All five wellness tests will be available to purchase on the
Company's website later today:
https://myhealthchecked.com/
Penny McCormick, Chief Executive Officer of MyHealthChecked Plc,
said: "I am delighted to announce the launch of our new suite of
at-home wellness tests and I am proud of the efforts of the
MyHealthChecked team that have allowed us to reach this milestone
on time. This is a significant achievement as we move into a new
phase of the business outside of the COVID-19 testing space.
"These initial tests are just the start of our consumer testing
portfolio, and we look forward to updating the market on further
portfolio developments throughout the course of 2022. Going forward
we will continue to engage with the market on potential
opportunities and re-invest the 2021 earnings from our COVID
testing services to explore additional third-party technology
options to further enhance the customer journey for our wellness
tests. We also continue our efforts to identify and assess
complementary earnings-enhancing partnerships ."
For further information contact:
MyHealthChecked plc www.myhealthchecked.com
P enny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Oberon Capital Ltd (Broker) Tel: +44 (0)203 179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44(0)
7407 804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests, now in development following the acquisition of The
Genome Store in November 2020. The tests will be made available
online, and would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDUOSNRUWUNAAR
(END) Dow Jones Newswires
June 14, 2022 02:00 ET (06:00 GMT)
MyHealthChecked (AQSE:MHC.GB)
Historical Stock Chart
From Oct 2024 to Nov 2024
MyHealthChecked (AQSE:MHC.GB)
Historical Stock Chart
From Nov 2023 to Nov 2024
